{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:44:20Z","timestamp":1793681060546,"version":"4.5.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,8,19]],"date-time":"2010-08-19T00:00:00Z","timestamp":1282176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00213-010-1994-5","type":"journal-article","created":{"date-parts":[[2010,8,18]],"date-time":"2010-08-18T12:27:14Z","timestamp":1282134434000},"page":"603-612","source":"Crossref","is-referenced-by-count":120,"title":["Memantine shows promise in reducing gambling severity and cognitive inflexibility in pathological gambling: a pilot study"],"prefix":"10.1007","volume":"212","author":[{"given":"Jon E.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Chamberlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Odlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suck Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,19]]},"reference":[{"key":"1994_CR1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.tics.2004.02.010","volume":"8","author":"AR Aron","year":"2004","unstructured":"Aron AR, Robbins TW, Poldrack RA (2004) Inhibition and the right inferior frontal cortex. Trends Cogn Sci 8:170\u2013177","journal-title":"Trends Cogn Sci"},{"key":"1994_CR2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1300.023","volume":"1003","author":"DA Baker","year":"2003","unstructured":"Baker DA, McFarland K, Lake RW, Shen H, Toda S, Kalivas PW (2003) N-acetyl cysteine-induced blockade of cocaine-induced reinstatement. Ann NY Acad Sci 1003:349\u2013351","journal-title":"Ann NY Acad Sci"},{"key":"1994_CR3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00213-003-1617-5","volume":"172","author":"A Bisaga","year":"2004","unstructured":"Bisaga A, Evans SM (2004) Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacol 172:16\u201324","journal-title":"Psychopharmacol"},{"key":"1994_CR4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.jcp.0000114844.58996.4a","volume":"24","author":"DW Black","year":"2004","unstructured":"Black DW (2004) An open-label trial of bupropion in the treatment of pathologic gambling. J Clin Psychopharmacol 24:108\u2013110","journal-title":"J Clin Psychopharmacol"},{"key":"1994_CR5","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.pnpbp.2008.02.013","volume":"32","author":"DW Black","year":"2008","unstructured":"Black DW, Shaw MC, Allen J (2008) Extended release carbamazepine in the treatment of pathological gambling: an open-label study. Prog Neuropsychopharmacol Biol Psychiatry 32:1191\u20131194","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1994_CR6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10401230209147393","volume":"14","author":"C Blanco","year":"2002","unstructured":"Blanco C, Petkova E, Ib\u00e1\u00f1ez A, S\u00e1iz-Ruiz J (2002) A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 14:9\u201315","journal-title":"Ann Clin Psychiatry"},{"key":"1994_CR7","volume-title":"CANTABeclipse, version 3","author":"Cambridge Cognition Limited","year":"2006","unstructured":"Cambridge Cognition Limited (2006) CANTABeclipse, version 3. Cambridge Cognition Limited, Cambridge"},{"key":"1994_CR8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2105\/AJPH.88.7.1093","volume":"88","author":"RM Cunningham-Williams","year":"1998","unstructured":"Cunningham-Williams RM, Cottler LB, Compton WM III, Spitznagel EL (1998) Taking chances: problem gamblers and mental health disorders\u2014results from the St. Louis Epidemiologic Catchment Area study. Am J Publ Health 88:1093\u20131096","journal-title":"Am J Publ Health"},{"key":"1994_CR9","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1530-0277.2007.00360.x","volume":"31","author":"SM Evans","year":"2007","unstructured":"Evans SM, Levin FR, Brooks DJ, Garawi F (2007) A pilot double-blind treatment trial of memantine for alcohol dependence. Alcohol Clin Exp Res 31:775\u2013782","journal-title":"Alcohol Clin Exp Res"},{"issue":"7","key":"1994_CR10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00002018-200831070-00003","volume":"31","author":"MR Farlow","year":"2008","unstructured":"Farlow MR, Graham SM, Alva G (2008) Memantine for the treatment of Alzheimer\u2019s disease: tolerability and safety data from clinical trials. Drug Saf 31(7):577\u2013585","journal-title":"Drug Saf"},{"key":"1994_CR11","volume-title":"Structured clinical interview for DSM-IV-patient edition (SCID-I\/P, Version 2.0)","author":"MB First","year":"1995","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV-patient edition (SCID-I\/P, Version 2.0). Biometrics Research Department, New York State Psychiatric Institute, New York"},{"key":"1994_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1037\/1040-3590.4.1.92","volume":"4","author":"MB Frisch","year":"1993","unstructured":"Frisch MB, Cornell J, Villaneuva M (1993) Clinical validation of the quality of life inventory: a measure of life satisfaction for use in treatment planning and outcome assessment. Psychol Assess 4:92\u2013101","journal-title":"Psychol Assess"},{"key":"1994_CR13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.comppsych.2004.07.022","volume":"46","author":"JE Grant","year":"2005","unstructured":"Grant JE, Kim SW (2005) Quality of life in kleptomania and pathological gambling. Compr Psychiatry 46:34\u201337","journal-title":"Compr Psychiatry"},{"key":"1994_CR14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.psc.2006.02.002","volume":"29","author":"JE Grant","year":"2006","unstructured":"Grant JE, Potenza MN (2006) Compulsive aspects of impulse control disorders. Psychiatr Clin North Am 29:539\u2013551","journal-title":"Psychiatr Clin North Am"},{"key":"1994_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.psychres.2004.05.006","volume":"128","author":"JE Grant","year":"2004","unstructured":"Grant JE, Steinberg MA, Kim SW, Rounsaville BJ, Potenza MN (2004) Preliminary validity and reliability testing of a structured clinical interview for pathological gambling (SCI-PG). Psychiatry Res 128:79\u201388","journal-title":"Psychiatry Res"},{"key":"1994_CR16","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1176\/appi.ajp.162.11.2184","volume":"162","author":"JE Grant","year":"2005","unstructured":"Grant JE, Levine L, Kim D, Potenza MN (2005) Impulse control disorders in adult psychiatric inpatients. Am J Psychiatry 162:2184\u20132188","journal-title":"Am J Psychiatry"},{"key":"1994_CR17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","volume":"163","author":"JE Grant","year":"2006","unstructured":"Grant JE, Potenza MN, Hollander E, Cunningham-Williams R, Nurminen T, Smits G, Kallio A (2006) A multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am J Psychiatry 163:303\u2013312","journal-title":"Am J Psychiatry"},{"key":"1994_CR18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.biopsych.2006.11.021","volume":"62","author":"JE Grant","year":"2007","unstructured":"Grant JE, Kim SW, Odlaug BL (2007) N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry 62:652\u2013657","journal-title":"Biol Psychiatry"},{"key":"1994_CR19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4088\/JCP.v69n0511","volume":"69","author":"JE Grant","year":"2008","unstructured":"Grant JE, Kim SW, Hartman BK (2008) A double-blind, placebo-controlled study of the opiate antagonist, naltrexone, for the treatment of pathological gambling urges. J Clin Psychiatry 69:783\u2013789","journal-title":"J Clin Psychiatry"},{"key":"1994_CR20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1192\/bjp.bp.108.062414","volume":"195","author":"JE Grant","year":"2009","unstructured":"Grant JE, Donahue CJ, Odlaug BL, Kim SW, Miller MJ, Petry NM (2009) Imaginal desensitization plus motivational interviewing in the treatment of pathological gambling: a randomized controlled trial. Br J Psychiatry 195:266\u2013267","journal-title":"Br J Psychiatry"},{"key":"1994_CR21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.comppsych.2009.04.002","volume":"51","author":"JE Grant","year":"2010","unstructured":"Grant JE, Schreiber L, Odlaug BL, Kim SW (2010) Pathologic gambling and bankruptcy. Compr Psychiatry 51:115\u2013120","journal-title":"Compr Psychiatry"},{"key":"1994_CR22","first-page":"218","volume-title":"ECDEU assessment manual for psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76\u2013338","author":"W Guy","year":"1976","unstructured":"Guy W (1976) ECDEU assessment manual for psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76\u2013338. National Institute of Mental Health, Rockville, pp 218\u2013222"},{"key":"1994_CR23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50\u201355","journal-title":"Br J Med Psychol"},{"key":"1994_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56\u201362","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1994_CR25","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/cercor\/bhj116","volume":"16","author":"A Hampshire","year":"2006","unstructured":"Hampshire A, Owen AM (2006) Fractionating attentional control using event-related fMRI. Cereb Cortex 16(12):1679\u20131689","journal-title":"Cereb Cortex"},{"issue":"3","key":"1994_CR26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.neuroimage.2009.12.109","volume":"50","author":"A Hampshire","year":"2010","unstructured":"Hampshire A, Chamberlain SR, Monti MM, Duncan J, Owen AM (2010) The role of the right inferior frontal gyrus: inhibition and attentional control. Neuroimage 50(3):1313\u20131319","journal-title":"Neuroimage"},{"key":"1994_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","volume":"162","author":"E Hollander","year":"2005","unstructured":"Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N (2005) Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 162:137\u2013145","journal-title":"Am J Psychiatry"},{"key":"1994_CR28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","volume":"49","author":"SW Kim","year":"2001","unstructured":"Kim SW, Grant JE, Adson DE, Shin YC (2001) Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 49:914\u2013921","journal-title":"Biol Psychiatry"},{"key":"1994_CR29","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.psychres.2007.11.008","volume":"166","author":"SW Kim","year":"2009","unstructured":"Kim SW, Grant JE, Potenza MN, Blanco C, Hollander E (2009) The Gambling Symptom Assessment Scale (G-SAS): a reliability and validity study. Psychiatry Res 166:76\u201384","journal-title":"Psychiatry Res"},{"key":"1994_CR30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1196\/annals.1300.010","volume":"1003","author":"JH Krystal","year":"2003","unstructured":"Krystal JH, Petrakis IL, Krupitsky E, Schutz C, Trevisan L, D'Souza DC (2003) NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann NY Acad Sci 1003:176\u2013184","journal-title":"Ann NY Acad Sci"},{"key":"1994_CR31","volume-title":"Neuropsychological assessment","author":"MD Lezak","year":"2004","unstructured":"Lezak MD, Howieson DB, Loring DW, Hannay HJ, Fischer JS (2004) Neuropsychological assessment. Oxford University Press, New York"},{"key":"1994_CR32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1037\/0096-1523.10.2.276","volume":"10","author":"GD Logan","year":"1984","unstructured":"Logan GD, Cowan WB, Davis KA (1984) On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10:276\u2013291","journal-title":"J Exp Psychol Hum Percept Perform"},{"key":"1994_CR33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0074-7742(09)89006-5","volume":"89","author":"YY Ma","year":"2009","unstructured":"Ma YY, Cepeda C, Cui CL (2009) The role of NMDA receptors in drug addiction. Int Rev Neurobiol 89:131\u2013146","journal-title":"Int Rev Neurobiol"},{"key":"1994_CR34","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/sj.npp.1301615","volume":"33","author":"F Meisner","year":"2008","unstructured":"Meisner F, Scheller C, Kneitz S, Sopper S, Neuen-Jacob E, Riederer P, Meulen V, Koutsilieri E (2008) Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine. Neuropsychopharmacol 33:2228\u20132236","journal-title":"Neuropsychopharmacol"},{"key":"1994_CR35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neuropharm.2008.02.014","volume":"54","author":"R Minkeviciene","year":"2008","unstructured":"Minkeviciene R, Banerjee P, Tanila H (2008) Cognition-enhancing and anxiolytic effects of memantine. Neuropharmacol 54:1079\u20131085","journal-title":"Neuropharmacol"},{"issue":"10","key":"1994_CR36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0028-3932(91)90063-E","volume":"29","author":"AM Owen","year":"1991","unstructured":"Owen AM, Roberts AC, Polkey CE, Sahakian BJ, Robbins TW (1991) Extra-dimensional versus intra-dimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 29(10):993\u20131006","journal-title":"Neuropsychologia"},{"key":"1994_CR37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10899-005-5557-3","volume":"21","author":"S Pallanti","year":"2005","unstructured":"Pallanti S, DeCaria CM, Grant JE, Urpe M, Hollander E (2005) Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). J Gambl Stud 21:431\u2013443","journal-title":"J Gambl Stud"},{"key":"1994_CR38","doi-asserted-by":"crossref","DOI":"10.1037\/10894-000","volume-title":"Pathological gambling: etiology, comorbidity, and treatment","author":"NM Petry","year":"2005","unstructured":"Petry NM (2005) Pathological gambling: etiology, comorbidity, and treatment. American Psychological Association, Washington"},{"key":"1994_CR39","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1037\/0022-006X.74.3.555","volume":"74","author":"NM Petry","year":"2006","unstructured":"Petry NM, Ammerman Y, Bohl J, Doersch A, Gay H, Kadden R, Molina C, Steinberg K (2006) Cognitive\u2013behavioral therapy for pathological gamblers. J Consult Clin Psychol 74:555\u2013567","journal-title":"J Consult Clin Psychol"},{"key":"1994_CR40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1525-1497.2002.10812.x","volume":"17","author":"MN Potenza","year":"2002","unstructured":"Potenza MN, Fiellin DA, Heninger GR, Rounsaville BJ, Mazure CM (2002) Gambling: an addictive behavior with health and primary care implications. J Gen Intern Med 17:721\u2013732","journal-title":"J Gen Intern Med"},{"issue":"6","key":"1994_CR41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.phrs.2010.02.009","volume":"61","author":"D Repantis","year":"2010","unstructured":"Repantis D, Laisney O, Heuser I (2010) Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review. Pharmacol Res 61(6):473\u2013481","journal-title":"Pharmacol Res"},{"key":"1994_CR42","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2105\/AJPH.89.9.1369","volume":"89","author":"HJ Shaffer","year":"1999","unstructured":"Shaffer HJ, Hall MN, Vander Bilt J (1999) Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Publ Health 89:1369\u20131376","journal-title":"Am J Publ Health"},{"key":"1994_CR43","volume-title":"The anxiety disease","author":"DV Sheehan","year":"1983","unstructured":"Sheehan DV (1983) The anxiety disease. Scribner's, New York"},{"key":"1994_CR44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-008-1364-8","volume":"202","author":"DS Tait","year":"2009","unstructured":"Tait DS, Marston HM, Shahid M, Brown VJ (2009) Asenapine restores cognitive flexibility in rats with medial prefrontal cortex lesions. Psychopharmacol (Berl) 202:295\u2013306","journal-title":"Psychopharmacol (Berl)"},{"key":"1994_CR45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","volume":"291","author":"PN Tariot","year":"2004","unstructured":"Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial. JAMA 291:317\u2013324","journal-title":"JAMA"},{"key":"1994_CR46","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/cercor\/bhp145","volume":"20","author":"H Wageningen Van","year":"2010","unstructured":"Van Wageningen H, Jorgensen HA, Specht K, Hugdahl K (2010) A 1H-MR spectroscopy study of changes in glutamate and glutamine (Glx) concentrations in frontal spectra after administration of memantine. Cereb Cortex 20:798\u2013803","journal-title":"Cereb Cortex"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-1994-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-010-1994-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-010-1994-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T20:07:19Z","timestamp":1558642039000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-010-1994-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,19]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1994"],"URL":"https:\/\/doi.org\/10.1007\/s00213-010-1994-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,19]]}}}